| Dr Kevin A Khater, MD, PHD | |
|
6308 8th Ave, Kenosha, WI 53143-5031 | |
| (262) 577-8206 | |
| (262) 577-8587 |
| Full Name | Dr Kevin A Khater |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 24 Years |
| Location | 6308 8th Ave, Kenosha, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710938550 | NPI | - | NPPES |
| 200860960 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 01063742A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| United Hospital System | Kenosha, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Froedtert South Inc | 9537071196 | 118 |
News Archive
Sucampo Pharmaceuticals, Inc. today announced that RESCULA (unoprostone isopropyl ophthalmic solution) 0.15% is now available by prescription across the United States. The U.S. Food and Drug Administration (FDA) approved a sNDA for RESCULA for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension on December 7, 2012.
The World Health Imaging, Telemedicine and Informatics Alliance (WHITIA) today unveiled Remi-d, a new product concept that is intended to provide remote-operated X-ray capabilities for use in screening across areas of the developing world experiencing the Human Immunodeficiency Virus (HIV) and Tuberculosis (TB) co-epidemic, high incidences of Black Lung disease, or outbreaks of other infectious respiratory diseases.
In late December in San Antonio, Texas, a 36-year-old mother of three from Jefferson City, Missouri, gave her best friend the most precious gift of all: a healthy kidney and the promise of a new life for the New Year.
Accumetrics, Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the VerifyNow P2Y12 Test is now CE marked for prognostic use in identifying patients with high residual platelet reactivity on antiplatelet therapy who are at greater risk for future cardiovascular events.
American researchers say when it comes to a teenager's risky sexual behaviour mothers deal with it differently to fathers and a father's usual response is to up the level of supervision and monitoring of their children.
› Verified 2 days ago
| Entity Name | Froedtert South Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558305284 PECOS PAC ID: 9537071196 Enrollment ID: O20031103000493 |
News Archive
Sucampo Pharmaceuticals, Inc. today announced that RESCULA (unoprostone isopropyl ophthalmic solution) 0.15% is now available by prescription across the United States. The U.S. Food and Drug Administration (FDA) approved a sNDA for RESCULA for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension on December 7, 2012.
The World Health Imaging, Telemedicine and Informatics Alliance (WHITIA) today unveiled Remi-d, a new product concept that is intended to provide remote-operated X-ray capabilities for use in screening across areas of the developing world experiencing the Human Immunodeficiency Virus (HIV) and Tuberculosis (TB) co-epidemic, high incidences of Black Lung disease, or outbreaks of other infectious respiratory diseases.
In late December in San Antonio, Texas, a 36-year-old mother of three from Jefferson City, Missouri, gave her best friend the most precious gift of all: a healthy kidney and the promise of a new life for the New Year.
Accumetrics, Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the VerifyNow P2Y12 Test is now CE marked for prognostic use in identifying patients with high residual platelet reactivity on antiplatelet therapy who are at greater risk for future cardiovascular events.
American researchers say when it comes to a teenager's risky sexual behaviour mothers deal with it differently to fathers and a father's usual response is to up the level of supervision and monitoring of their children.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin A Khater, MD, PHD 6308 8th Ave, Kenosha, WI 53143-5031 Ph: (262) 577-8206 | Dr Kevin A Khater, MD, PHD 6308 8th Ave, Kenosha, WI 53143-5031 Ph: (262) 577-8206 |
News Archive
Sucampo Pharmaceuticals, Inc. today announced that RESCULA (unoprostone isopropyl ophthalmic solution) 0.15% is now available by prescription across the United States. The U.S. Food and Drug Administration (FDA) approved a sNDA for RESCULA for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension on December 7, 2012.
The World Health Imaging, Telemedicine and Informatics Alliance (WHITIA) today unveiled Remi-d, a new product concept that is intended to provide remote-operated X-ray capabilities for use in screening across areas of the developing world experiencing the Human Immunodeficiency Virus (HIV) and Tuberculosis (TB) co-epidemic, high incidences of Black Lung disease, or outbreaks of other infectious respiratory diseases.
In late December in San Antonio, Texas, a 36-year-old mother of three from Jefferson City, Missouri, gave her best friend the most precious gift of all: a healthy kidney and the promise of a new life for the New Year.
Accumetrics, Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the VerifyNow P2Y12 Test is now CE marked for prognostic use in identifying patients with high residual platelet reactivity on antiplatelet therapy who are at greater risk for future cardiovascular events.
American researchers say when it comes to a teenager's risky sexual behaviour mothers deal with it differently to fathers and a father's usual response is to up the level of supervision and monitoring of their children.
› Verified 2 days ago
Lawrence Rufer, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-5600 | |
Dr. Mohsin Yunus Ghadiali, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 6308 8th Ave, Kenosha, WI 53143 Phone: 414-290-6720 Fax: 414-290-6755 | |
Peter R Hulick, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 4623 75th St # 338, Kenosha, WI 53142 Phone: 617-312-9747 | |
Dr. Joshua Knute Elson, MD, MPH Radiology Medicare: Accepting Medicare Assignments Practice Location: 6811 118th Ave, Kenosha, WI 53142 Phone: 262-857-5750 | |
Dr. Luke A Falesch, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-7000 | |
Steven D Huffman, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-5600 Fax: 262-948-5735 |